NAMI Ask the Expert: A Fireside Chat with Dr. Marlene Freeman and Dr. Ken Duckworth
Dr. Marlene Freeman recently shared her insights on Psychiatric Medications and Considerations for Individuals Across Pregnancy, the Postpartum, and Reproductive Years with the National Alliance on Mental Illness on March 7, 2024.
Which is Safer for the Treatment of Opioid Use Disorder During Pregnancy: Buprenorphine or Methadone?
In this large cohort study analyzing data from publicly insured Medicaid beneficiaries, the overall risk of malformations was lower with buprenorphine than with methadone.
Depression During Pregnancy Is a Risk Factor for Postpartum Depression, Does Timing Matter?
Women who experienced depression during pregnancy were about four times as likely to experience PPD compared to women with no depression during pregnancy, with greater risk associated with depression during the first and third trimesters.
Allison Baker, MD on the Specialized Care of Pregnant and Postpartum Women with ADHD
To better care for pregnant and postpartum mothers with ADHD, clinicians should understand the unique facets of ADHD in women, how symptoms change during pregnancy and the postpartum period, and how to help new parents make decisions around medication use and ADHD symptom management.
Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development
At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
Weekly Roundup for February 23, 2024: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.